School of Medicine
Showing 21-40 of 292 Results
-
Christine Jacobs-Wagner
Dennis Cunningham Professor, Professor of Biology and of Microbiology and Immunology
BioChristine Jacobs-Wagner is a Dennis Cunningham Professor in the Department of Biology and the ChEM-H Institute at Stanford University. She is interested in understanding the fundamental mechanisms and principles by which cells, and, in particular, bacterial cells, are able to multiple. She received her PhD in Biochemistry in 1996 from the University of Liège, Belgium where she unraveled a molecular mechanism by which some bacterial pathogens sense and respond to antibiotics attack to achieve resistance. For this work, she received multiple awards including the 1997 GE & Science Prize for Young Life Scientists. During her postdoctoral work at Stanford Medical School, she demonstrated that bacteria can localize regulatory proteins to specific intracellular regions to control signal transduction and the cell cycle, uncovering a new, unsuspected level of bacterial regulation.
She started her own lab at Yale University in 2001. Over the years, her group made major contributions in the emerging field of bacterial cell biology and provided key molecular insights into the temporal and spatial mechanisms involved in cell morphogenesis, cell polarization, chromosome segregation and cell cycle control. For her distinguished work, she received the Pew Scholars award from the Pew Charitable Trust, the Woman in Cell Biology Junior award from the American Society of Cell Biology and the Eli Lilly award from the American Society of Microbiology. She held the Maxine F. Singer and William H. Fleming professor chairs at Yale. She was elected to the Connecticut academy of Science, the American Academy of Microbiology and the National Academy of Sciences. She has been an investigator of the Howard Hughes Medical Institute since 2008.
Her lab moved to Stanford in 2019. Current research examines the general principles and spatiotemporal mechanisms by which bacterial cells replicate, using Caulobacter crescentus and Escherichia coli as models. Recently, the Jacobs-Wagner lab expanded their interests to the Lyme disease agent Borrelia burgdorferi, revealing unsuspected ways by which this pathogen grows and causes disease -
Gunilla B Jacobson
Director, Translational Medicine and Technical & Strategic Director, Cyclotron, Rad/Precision Health and Integrated Diagnostics
Current Role at StanfordDirector of Translational Medicine, DeSimone Lab
Technical and Strategic Director, Cyclotron -
Karen Blake Jacobson
Adjunct Clinical Assistant Professor, Medicine
BioDr. Jacobson is Postdoctoral Medical Fellow in the Division of Infectious Diseases and Geographic Medicine. She previously received her MD and MPH from Icahn School of Medicine at Mount Sinai and completed residency in Internal Medicine/HIV Primary Care at Yale. She is board certified in Internal Medicine and Infectious Diseases. Dr. Jacobson’s current research focus is on the epidemiology and natural history of SARS-CoV-2, and the interactions between SARS-CoV-2 and malaria in pregnancy in malaria endemic settings.
-
Mojtaba Jafaritadi
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsDr. Jafaritadi is working on signal processing and machine learning applications in cancer, cardiac, and brain PET imaging. His research focuses on generative AI for image correction, image-to-image translation, and image denoising. He is also interested in working on data- and device-driven motion tracking and correction systems for PET imaging using deep neural networks.
-
Prasanna Jagannathan
Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
BioI am an Infectious Diseases physician-scientist with a research program in human immunology of malaria and clinical trials of immune modulatory interventions. Our group has been conducting detailed longitudinal cohort studies in children and pregnant women in order to study how repeated malaria shapes the cellular immune response. We are also studying how malaria control interventions such as antimalarial chemoprevention and vector control shape the acquisition and/or maintenance of protective immunity to malaria. We have expanded this work to not only include studying the mechanisms driving naturally acquired immunity to malaria, but other infectious diseases, including SARS CoV-2. We have also lead and/or participated in studies evaluating therapeutic strategies for patients with mild to moderate COVID-19.
-
Annemarie Jagielo
Casual - Non-Exempt, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordDoctoral Student, Clinical Psychology, PGSP-Stanford PsyD Consortium
-
Hassan Jahanandish
Postdoctoral Scholar, Urology
BioDr. Hassan Jahanandish is a Postdoctoral Fellow at Stanford School of Medicine, where his research focuses on the intersection of multimodal AI and medical imaging with the overarching objective of advancing care paradigms for cancer patients. Before joining Stanford, he completed his PhD in Bioengineering at the University of Texas at Dallas and the University of Texas Southwestern Medical Center (2022). Beyond his research pursuits, Hassan is an Instructor and Team Mentor at Stanford Center for Biodesign, where he helps shape the future of medical innovation and healthcare entrepreneurship. Hassan's scholarly contributions have been published in numerous journals and conferences, and his work in collaboration with Nokia Bell Labs has been awarded a United States patent. Hassan's achievements have been recognized by awards such as the Jonsson Family Graduate Fellowship in Bioengineering, the Doctoral Dissertation Research Award, and being an International RehabWeek paper award finalist (2019).
-
Fereshteh Jahanbani
Basic Life Research Scientist, Genetics
BioDr. Jahanbani received her PharmD from Tehran University of Medical Sciences (TUMS) and PhD in pharmacology from Iran University of Medical Sciences (IUMS) and her postdoctoral degree from Case Western Reserve University (CWRU) and University of California, Santa Cruz (UCSC). She joined Stanford Center for Genomics and Personalized Medicine in June 2012. Her work is focused on better understanding the etiology of chronic complex conditions and multi-morbidity using multi-omics and precision health approaches. She has been leading ME/CFS related disorders multi-omics study combining the power of both family and population approaches and also cofounded “Research To The People at Stanford Program”.